Skip to main content

Cannabis company Curaleaf draws downgrade to hold at Benchmark, while Wedbush sticks to outperform

Benchmark flags cannabis market "uncertainty" while Wedbush sees "good start" to 2023 after Curaleaf beats revenue target, posts narrower-than-expected loss.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.